GTHP
Guided Therapeutics, Inc.
OTCQB
Contact Info
- 5835 Peachtree Corners East
- Suite D
- Norcross, GA 30092
- Website: http://www.guidedinc.com
- Phone: 770-242-8723
- Email: info@guidedinc.com
Update Company Info
Business Description
Guided Therapeutics, Inc. is developing a rapid and painless test for the early detection of disease that leads to cervical cancer. The technology is designed to quickly eliminate false positive Pap and HPV results and discover cervical disease missed by existing tests. Unlike Pap and HPV tests, the device does not require a painful tissue sample and results are known immediately. The company also owns technology for measuring substances in interstitial fluid, a secondary circulatory system in ...
More >>
Financial Reporting/Disclosure
| Reporting Status | U.S. Reporting: SEC Filer |
| Audited Financials | Audited |
| Latest Report | Not Available |
| Regulatory Agency | Not Available |
| CIK | 0000924515 |
| Fiscal Year End | 12/31 |
| OTC Market Tier | OTCQB |
Profile Data
| SIC - Industry Classification | 3845 - Electromedical equipment |
| Incorporated In: | DE, USA |
| Year of Inc. | 1992 |
| Employees | 21 a/o Dec 31, 2006 |
Company Officers
| Mark L. Faupel | President, CEO, Secretary |
| Bill Wells | Director, Corp. Comm. |
Company Directors
| William E. Zachary | Chairman |
| Mark L. Faupel | |
| Ronald W. Hart | |
| John E. Immhoff | |
| Michael C. James |
Company Notes
- Formerly=SpectRx, Inc. until 5-2008
GTHP Security Details
Share Structure
| Market Value1 | $41,298,383 | a/o May 23, 2012 |
| Shares Outstanding | 52,946,645 | a/o May 07, 2012 |
| Float | 7,248,000 | a/o Apr 09, 2007 |
| Authorized Shares | 50,000,000 | a/o Apr 09, 2007 |
| Par Value | 0.001 |
Shareholders
| Shareholders of Record | 171 | a/o Mar 28, 2012 |
Short Selling Data
| Short Interest | 14,027 (-1.63%) Apr 30, 2012 |
| Significant Failures to Deliver | No |
Transfer Agent(s)
| Computershare Investor Services LLC |
1Market Value calculated only for respective security
